Controversies, new risk factors and the neuroendocrine approach to fibromyalgia: can therapeutic progress be made at last?
Shipton
Edward
E
Department of Anaesthesia, Christchurch School of Medicine and Health Sciences, University of Otago, Christchurch, New Zealand. shiptonea@xtra.co.nz.
D000728:Androgens / Q000378:metabolism; D005356:Fibromyalgia / Q000209:etiology*; D005544:Forecasting; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000502:physiology*; D009765:Obesity / Q000150:complications; D010913:Pituitary-Adrenal System / Q000502:physiology*; D012307:Risk Factors
D000728:Androgens